"Moody’s Investor Services thinks these are just the start, with M&A activity expected to remain high over the next year to 18 months. Pharmas are trying to restock their pipelines due to approaching patent cliffs and long-term pricing pressure"........
Bring on the auction action.....starting point with one Phase 2 positive result would have to be $50 / share ? ...and thereon upwards...
Merck to acquire Prometheus in a US$ 10.8 b deal, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
0.085(0.58%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $14.36 | $14.68 | $14.25 | $1.950M | 134.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 255 | $14.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.68 | 408 | 9 |
View Market Depth
| Last trade - 14.17pm 16/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |